GPX Medical publicerar idag Bokslutskommuniké för år 2020. Läs pressmeddelandet och rapporten i sin helhet här: Bokslutskommuniké 2020
Aktieägare och intressenter är varmt välkomna till bolagets rapportpresentation den 16 februari 2021 kl. 10.00. För anmälan och videolänk, kontakta Marketing and Communication Lead Freja Bremborg freja.bremborg@gpxmedical.se
Rapportpresentationen kommer att finnas tillgänglig på bolagets hemsida senare under dagen.
GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.
Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se
GPX Medical AB (publ)
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se
Organization number: 559069-9012
